Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer
Summary: Background/Objective: Neoadjuvant chemotherapy (NAC) is a standard treatment for locally advanced breast cancer, especially for HER2-positive or triple negative breast cancer which shows good response to chemotherapy. However, because a result of biomarkers is, occasionally, changed after...
| Główni autorzy: | , , , , , , , , , , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
Elsevier
2020-03-01
|
| Seria: | Asian Journal of Surgery |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S1015958419302398 |